GURUGRAM: The food and drugs administration may serve a show-cause notice to a  . 

 The move comes following an inquiry in   Pratap’s case who was treated for dengue at a city private hospital. 
 
 “We are seeking technical opinion before finalising the notice. The company will get 15-days time to respond,” said  , drug control officer, Gurugram.
 
 He added that every company has to get the MRP approved by the national pharmaceutical pricing authority (NPPA) when they launch a new drug. However, this company that manufactured dexamethasone injection, which was used in Saurya’s treatment, had an MRP which was higher than the prescribed price.
 
 
